bioMérieux Sweden AB
556266-0653ActiveWorld leader developing in vitro diagnostics for health and safety.
Overview
- 20–49
- Employees
- 100–500M SEK
- Revenue
- 1985
- Founded
Key Decision Makers
Pierre Boulud
Chief Executive Officer
Charles K. Cooper
Executive Vice President, Chief Medical Officer
Audrey Dauvet
Executive Vice President, Legal, Corporate Integrity & Public Affairs
Bénédicte Blot
Vice President, HSE
+11 more contacts in Funnelfeedr
Description
bioMérieux is a family-owned company recognized globally as a world leader in the field of in vitro diagnostics (IVD). Their core mission is dedicated to improving public health worldwide through pioneering diagnostic solutions. The company specializes in clinical applications, providing healthcare...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Partihandel med mät- och precisionsinstrument
- Legal Form
- Aktiebolag
- VAT Number
- SE556266065301
Decision Makers
15 contacts in FunnelfeedrPierre Boulud
Chief Executive Officer
Charles K. Cooper
Executive Vice President, Chief Medical Officer
Audrey Dauvet
Executive Vice President, Legal, Corporate Integrity & Public Affairs
Bénédicte Blot
Vice President, HSE
Valérie Leyldé
Executive Vice President, Human Resources, Communication & CSR
Yasha Mitrotti
Executive Vice President, Industrial Applications
Alexandre Mérieux
Chairman of the Board of Directors
Alain Mérieux
Founding President
Jennifer Zinn
Executive Vice President, Clinical Operations
Céline Roger-Dalbert
Executive Vice President, Research & Development
Pierre Charbonnier
Executive Vice President, Global Quality, Manufacturing and Supply Chain
Guillaume Bouhours
Chief Financial Officer, Executive Vice President, Purchasing and Information Systems
Other Contacts
Olivier Rescanière
Media Contact
Romain Duchez
Media Contact
Sylvain Orenga
Director representing employees
Similar Companies
20 similar companies in FunnelfeedrLumiraDx Aktiebolag
Global leader providing advanced in-vitro diagnostic solutions at the point of need.
CERUS EUROPE BV
Cerus Corporation develops vital technologies to secure the global blood supply.
Gradientech AB
20–49 employeesDeveloping ultra-rapid diagnostic systems for antibiotic susceptibility testing.
Sangair AB
5–9 employeesDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Amferia AB
5–9 employeesDeveloping peptide hydrogel technology to combat bacterial infections safely.
Browse More
bioMérieux Sweden AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo